[144] Cardinal Health, Inc. SEC Filing

Rhea-AI Filing Summary

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 21,367 common shares through Merrill Lynch on 08/20/2025 with an aggregate market value of $3,216,330.00. The filing shows the shares were acquired on 08/15/2025 from Cardinal Health, Inc. as 13,088 shares from performance stock vesting and 8,279 shares from restricted stock vesting. No securities were reported sold by the same person in the past three months. The document includes the required representation that the seller is not aware of undisclosed material adverse information and references potential Rule 10b5-1 plan considerations.

Insights

Securities/Corporate Transactions Analyst

TL;DR: Routine insider sale notice for newly vested equity; documents compliance with Rule 144 disclosure requirements.

The Form 144 notifies the brokered sale of 21,367 newly vested Cardinal Health common shares, specifying the vesting dates and vesting types (performance and restricted stock). The filing identifies the broker (Merrill Lynch) and the proposed sale date (08/20/2025). From a transactions perspective this is a standard disclosure enabling a registered broker to effect a sale under Rule 144; it does not itself confirm execution of the sale or indicate other material corporate developments.

Corporate Governance / Insider Trading Specialist

TL;DR: Disclosure meets procedural requirements; raises routine governance considerations around timing and trading plans.

The filer represents no undisclosed material adverse information and the form references Rule 10b5-1 plan adoption or instructions as applicable. The details provided (acquisition by vesting on 08/15/2025, proposed sale on 08/20/2025, broker identified) are consistent with standard insider liquidity events following equity award vesting. The filing is informational; any governance implications depend on context not provided here (e.g., existence and adoption date of a trading plan).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Dr. 5th Floor Columbus OH 43240	21367	3216330.00	238793647	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Performance Stock Vesting	CARDINAL HEALTH INC			13088	08/15/2025	NA
Common	08/15/2025	Restricted Stock Vesting	CARDINAL HEALTH INC			8279	08/15/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cardinal Health's (CAH) Form 144 report?

It reports a proposed sale of 21,367 common shares through Merrill Lynch with aggregate market value of $3,216,330.00, proposed for 08/20/2025.

How were the 21,367 shares acquired according to the filing?

The shares were acquired on 08/15/2025 via performance stock vesting (13,088 shares) and restricted stock vesting (8,279 shares) from Cardinal Health, Inc.

Did the filer sell any Cardinal Health securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is named to handle the proposed sale?

Merrill Lynch is listed with an address at 8890 Lyra Dr., 5th Floor, Columbus, OH 43240.

Does the Form 144 state the filer has undisclosed material information?

No. The filer represents by signature that they do not know any material adverse information not publicly disclosed.